News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
289–324
Matches
464
Sources here
24
Companies here
14
Search results Stored financial headlines

Active search

464 matching headlines

Ticker or company: TEAMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

NetEase stock trades steady as latest earnings highlight growth in games and education

NetEase (NTES) has shown steady stock performance, driven by robust growth in its online games and education segments. The company reported a 12% year-on-year revenue increase in Q1 2026, reaching RMB 27.0 billion, with significant contributions from gaming, Youdao education, and Cloud Music, alongside …

NTES main company
Sharemaestro market context Trend signal active 52 weeks -2.8% NTES stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NetEase Number of Employees 2026 | Employee Count & Headcount Data

NetEase, Inc. had approximately 25,342 employees worldwide as of March 2026, marking a 7.9% decline from 27,513 employees in 2023. The company, headquartered in Hangzhou, China, is actively hiring with 196 job postings in 2026, though this represents a significant 69.1% decline from 2025. …

NTES main company
Sharemaestro market context Trend signal active 52 weeks -2.8% NTES stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus

Atea Pharmaceuticals has announced the initiation of a first-in-human Phase 1 clinical trial for AT-587, an oral antiviral nucleotide analog designed to treat hepatitis E virus (HEV). This marks a significant step towards addressing the unmet medical need for HEV, especially in immunocompromised individuals, …

AVIR main company
Sharemaestro market context Price above Trend Line 52 weeks +39.9% AVIR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NetEase, Inc. Podcast | NTES Podcasts & Related Content

This page provides an overview of NetEase, Inc. (NTES), including its stock performance, key financial metrics, and access to related podcast content. It shows the current stock price, daily changes, market capitalization, and earnings date, along with disclaimers regarding the informational nature of the …

NTES main company
Sharemaestro market context Trend signal active 52 weeks -2.8% NTES stored weekly price path from 22 Aug 2025 to 14 Aug 2026

WARNER MUSIC GROUP AND NETEASE CLOUD MUSIC ANNOUNCE STRATEGIC MULTI-YEAR LICENSING RENEWAL

Warner Music Group (WMG) and NetEase Cloud Music have renewed their strategic multi-year licensing agreement, deepening their partnership in China. The collaboration will expand beyond distributing WMG's catalog to include promoting WMG artists with dedicated marketing and multimedia content, leveraging NetEase Cloud Music's interactive …

NTES main company
Sharemaestro market context Trend signal active 52 weeks -2.8% NTES stored weekly price path from 22 Aug 2025 to 14 Aug 2026

StealthGas Company Profile & Introduction

This document appears to be a stub or an incomplete article. It only contains the single word "Document" and does not provide any information about StealthGas or its profile. Therefore, a meaningful summary is not possible based on the provided content.

GASS main company
Sharemaestro market context Price above Trend Line 52 weeks +30.7% GASS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

William Blair Maintains Atea Pharmaceuticals(AVIR.US) With Buy Rating

William Blair has reiterated its Buy rating for Atea Pharmaceuticals (AVIR.US). The article does not provide further details on the rationale behind this rating or any specific financial analysis.

AVIR main company
Sharemaestro market context Price above Trend Line 52 weeks +39.9% AVIR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

NetEase (NASDAQ: NTES) revises 2019 equity plan for Hong Kong listing

NetEase, Inc. (NASDAQ: NTES) has revised its 2019 share incentive plan, now termed the "Second Amended and Restated 2019 Share Incentive Plan," effective June 30, 2026. This amendment is in preparation for its conversion to dual primary listing status on the Stock Exchange of …

NTES main company
Sharemaestro market context Trend signal active 52 weeks -2.8% NTES stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context